Theramex
Edward Rees is a seasoned business development executive currently serving as the Senior Director of Business Development at Theramex, focusing on innovative medicines for women. Prior to this role, Edward held various senior positions at Norgine, including Senior Director of Business Development, where responsibilities encompassed launching innovative treatments in Europe and managing a substantial portfolio of established brands. Edward's extensive experience in corporate law was developed during a tenure at SJ Berwin, providing legal counsel on complex mergers and acquisitions. Edward holds a degree in Modern History from the University of Oxford and has pursued further education in law and pharmaceutical forecasting.
This person is not in any teams
This person is not in any offices
Theramex
We are Theramex // www.theramex.com info@theramex.com A new global women's healthcare company that provides innovative, effective and safe solutions that care for and support women at every stage of their life. Our aim is to become a lifetime partner for women and for the healthcare professionals who treat them. Theramex has been a recognised brand for many decades - but since the purchase of Teva Pharmaceuticals' (Teva) Women's health division in February 2018, Theramex has been re-born as a separate, privately-held company dedicated to Women's Health. Theramex currently operates in 50 countries, across 5 continents. Our team is made up of around 500 passionate and multi-disciplinary medical professionals, supported by a network of distributors. Our established product portfolio offers a wide range of clinically proven prescription products in 4 clinical areas: - Contraception - Fertility - Menopause - Osteoporosis We are actively looking to expand our product portfolio and geographical presence. We would love to hear about interesting partnership opportunities. We are actively recruiting in London as well as other geographies across the world - please see our Careers Page for further details, or get in touch with us. Please read our T&C's on our website.